Understanding variants in GIPR and FTO, and MC4R can support a more informed conversation with your provider about whether a lower-cost microdose protocol or a higher-potency compound better aligns with your predicted metabolic response
it also has a significant impact on your digestive system
Key Takeaways Semaglutide produces clinically significant weight loss the STEP 1 trial demonstrated a mean 14.9% body weight reduction at 68 weeks with the 2.4 mg dose The dose escalation schedule is medically necessary, not optional rushing it leads to severe GI side effects that cause most treatment discontinuations Semaglutide is a long-term medication weight returns if treatment is stopped, as shown in the STEP 1 extension trial It carries real contraindications including a family history of medullary thyroid carcinoma, MEN2, pregnancy, and severe GI disease Drug interactions with oral medications are clinically relevant your full medication list must be reviewed by a pharmacist or physician before starting Maximum benefit requires combining semaglutide with a healthy diet and physical activity it reduces appetite, but it does not replace lifestyle modification References Wilding JPH, Batterham RL, Calanna S, et al

Obesity is defined as: A body mass indexBMIof 30 kg/m2 or greater) Overweight is defined as: A BMI of 27 kg/m2 or greater These drugs are expensive
If you get acne flares, start with a smaller amount and avoid pairing it with strong acids on day one
These checkups may include checking blood pressure, heart rate, weight, and lab tests